Viewing Study NCT06625593

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:01 AM
Ignite Modification Date: 2025-12-25 @ 11:15 PM
Study NCT ID: NCT06625593
Status: RECRUITING
Last Update Posted: 2025-11-21
First Post: 2024-09-23
Is NOT Gene Therapy: False
Has Adverse Events: False
Brief Title: A First-in-Human (FIH) Study of BG-C137, an Anti-Fibroblast Growth Factor Receptor 2b (FGFR2b) Antibody Drug Conjugate, in Participants With Advanced Solid Tumors
Sponsor: BeOne Medicines
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Tumor View
Keywords:

Keywords

Keyword Brief Keyword Text View
None BG-C137 View
None Advanced Solid Tumor View
None First-in-human View
None FGFR2b View
None ADC View
None Fibroblast growth factor receptor 2b View